United Therapeutics Corporation Reports Fourth Quarter and Full Year 2021 Financial Results
Go back to United Therapeutics Corporation Reports Fourth Quarter and Full Year 2021 Financial Results| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 536.59 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $536.59 | 52 Week High | $164.04 | |||
| Open | $536.59 | 52 Week Low | $97.52 | |||
| Day High | $536.59 | P/E | 98.10 | |||
| Day Low | $536.59 | EPS | $5.47 | |||
| Volume | 256 | |||||
